Cytosorbents Corporation 8-K Report: Key Updates for Investors on January 13, 2025

Based on the provided section of the financial report, here are the key insights extracted:

1. Entity Information:

• Company Name: Cytosorbents Corporation
• CIK: 0001175151
• SEC File Number: 001-36792
• Tax ID: 98-0373793
• Address: 305 College Road East, Princeton, NJ 08540
• Contact Number: 732-329-8885

2. Filing Type and Date:

• Filing Type: 8-K (This indicates a current report that companies must file with the SEC to announce major events that shareholders should know about.)
• Filing Date: January 13, 2025

3. Stock Information:

• Common Stock:
• • Par Value: $0.001
  • Ticker Symbol: CTSO
  • Exchange: NASDAQ

4. Context and Measurement:

• The report is structured in XBRL (eXtensible Business Reporting Language), which is used for digital financial reporting.
• The financial reporting context is specifically for a single day: January 13, 2025.
• The currency used in the report is US Dollars (USD), and it also mentions shares as a unit of measure.

5. Key XML Tags:

• The report references a schema file (ctso-20250113.xsd), indicating the structure of the data being reported.
• It includes various namespaces associated with XBRL.

Insights:

• This filing indicates that Cytosorbents Corporation is actively communicating significant updates to its investors, as mandated by the SEC.
• The reference to common stock suggests that the company may be involved in corporate actions affecting its equity, which could be of interest to investors.
• The structured data format (XBRL) enhances transparency and facilitates analysis by investors and analysts.

Overall, this report serves as an important update for stakeholders regarding company activities on the specified date.